Cannabinoids and Cardiovascular System

Area of Science:

• Cardiovascular Pharmacology
• Endocannabinoid System Research

Background:

• Cannabinoids exert significant influence on cardiovascular variables in both healthy and diseased states.
• The endocannabinoid system (ECS) is implicated in cardiovascular physiology and pathology, showing overactivation in disease.

Purpose of the Study:

• To critically analyze the signaling pathways regulating cardiovascular function by endogenous and exogenous cannabinoids.
• To investigate the dual role of the ECS in cardiovascular diseases, including protective and pathophysiological effects.

Main Methods:

• Review of marijuana smoking effects on the cardiovascular system.
• Analysis of exogenous cannabinoid impacts on cardiovascular parameters in humans and experimental animals.
• Examination of cannabinoid effects on isolated vessel reactivity.

Main Results:

• The ECS demonstrates both protective compensatory roles (e.g., hypertension, atherosclerosis) and pathophysiological roles (e.g., hypotension).
• Cannabinoids induce vascular relaxation via receptor-dependent and -independent mechanisms.
• Dysregulation of vascular endocannabinoid signaling is observed in disease states.

Conclusions:

• Cannabinoids have complex and multifaceted effects on cardiovascular function.
• Understanding cannabinoid signaling is crucial for managing cardiovascular health and disease.